Technical Analysis for AVGR - Avinger, Inc.

Grade Last Price % Change Price Change
F 6.56 -0.15% -0.01
AVGR closed down 0.15 percent on Thursday, September 28, 2023, on 7 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -0.15%
Wide Bands Range Expansion -0.15%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 11 hours ago
Down 3% about 14 hours ago
Fell Below Previous Day's Low about 14 hours ago
Down 2 % about 14 hours ago
Down 1% about 15 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avinger, Inc. Description

Avinger, Inc., a medical device company, designs, manufactures, and sells image-guided, catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD). It offers Lightbox, an imaging console, which enables the use of lumivascular catheters during PAD procedures; Ocelot, a chronic total occlusion (CTO) crossing catheter, which allows physicians to see the inside of an artery during a CTO crossing procedure; Ocelot PIXL, a lower profile CTO-crossing device for below-the-knee arteries; and Ocelot MVRX, a device which offers a tip design for above-the-knee arteries. The company also provides Wildcat, a catheter that facilitates the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention; and Kittycat 2, a catheter that facilitate the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists directly in the United States and Europe. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Imaging Catheter Medical Imaging Interventional Radiology Knee Artery Cordis Interventional Cardiology Percutaneous Peripheral Arterial Disease

Is AVGR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.21
52 Week Low 4.13
Average Volume 2,325,882
200-Day Moving Average 12.23
50-Day Moving Average 8.82
20-Day Moving Average 7.30
10-Day Moving Average 8.50
Average True Range 1.57
RSI (14) 48.19
ADX 47.33
+DI 31.76
-DI 22.58
Chandelier Exit (Long, 3 ATRs) 9.30
Chandelier Exit (Short, 3 ATRs) 8.83
Upper Bollinger Bands 12.01
Lower Bollinger Band 2.60
Percent B (%b) 0.42
BandWidth 128.85
MACD Line -0.06
MACD Signal Line -0.11
MACD Histogram 0.0489
Fundamentals Value
Market Cap 557.09 Million
Num Shares 84.9 Million
EPS -7.02
Price-to-Earnings (P/E) Ratio -0.93
Price-to-Sales 1.01
Price-to-Book 1.67
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.51
Resistance 3 (R3) 7.51 7.20 7.35
Resistance 2 (R2) 7.20 6.96 7.20 7.29
Resistance 1 (R1) 6.88 6.81 6.73 6.88 7.24
Pivot Point 6.57 6.57 6.49 6.57 6.57
Support 1 (S1) 6.25 6.33 6.10 6.25 5.88
Support 2 (S2) 5.94 6.18 5.94 5.83
Support 3 (S3) 5.62 5.94 5.77
Support 4 (S4) 5.62